CR
Capital Research Global Investors disclosed a 7% stake in VRTX
Capital Research Global Investors reported owning 7% of Vertex Pharmaceuticals Inc / Ma (VRTX) (17,821,661 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G